RE/MAX (RMAX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 14, 2025, to be held virtually for the ninth consecutive year, allowing broader shareholder participation and cost savings.
Key business in 2024 included strategic initiatives to diversify revenue, operational efficiency improvements, and leadership changes, including the appointment of a new CEO and a new board member.
Financial highlights for 2024: $307.7M revenue, $8.1M net income, $97.7M adjusted EBITDA, and a 1.2% increase in agent count to 146,627.
Settled multiple industry class-action lawsuits and continued to invest in technology, education, and marketing for franchise networks.
Voting matters and shareholder proposals
Election of three directors: David Liniger, Annita Menogan, and Teresa Van De Bogart, each for a three-year term.
Advisory vote on executive compensation (say-on-pay).
Approval of an amendment to the 2023 Omnibus Incentive Plan to increase authorized shares by 2,800,000.
Ratification of Ernst & Young LLP as independent registered public accounting firm for 2025.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board will have nine members post-meeting, with 70% independence and a mix of tenures for stability and fresh perspectives.
Separate Chair and CEO roles, with a robust Lead Independent Director position.
Board committees (Audit, Compensation, Nominating and Corporate Governance) are fully independent.
Board refreshment ongoing: one new member added in 2024, two in 2023.
Annual board and committee self-assessments, commitment to director education, and regular stockholder engagement.
Latest events from RE/MAX
- Q4 revenue and EBITDA declined, but global agent count hit a record and 2026 outlook is positive.RMAX
Q4 202520 Feb 2026 - Adjusted EBITDA rose 5.4% to $28.1M despite a 4.8% revenue decline in Q2 2024.RMAX
Q2 20241 Feb 2026 - Adjusted EBITDA rose 2% to $27.3M as cost controls and global agent growth offset U.S. declines.RMAX
Q3 202417 Jan 2026 - Modest U.S. housing growth, industry adaptation, and franchise-driven cash flow support future expansion.RMAX
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Adjusted EBITDA rose despite revenue decline, with international agent growth offsetting U.S. losses.RMAX
Q4 202424 Dec 2025 - Virtual annual meeting to vote on directors, pay, incentive plan, and auditor ratification.RMAX
Proxy Filing1 Dec 2025 - Revenue fell but margins improved as global agent growth offset North America decline.RMAX
Q1 202523 Nov 2025 - Record agent count offset U.S. declines as revenue and EBITDA fell but margin improved.RMAX
Q2 202516 Nov 2025 - Q3 2025: Revenue down, margins up, record agent count, and innovation drive resilience.RMAX
Q3 20253 Nov 2025